1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > 2017-2021 France Hospital Infectious Disease Market: Emerging Opportunities and Growth Strategies for Suppliers

This new report from VPGMarketResearch.com contains 897 pages, 77 tables, and presents a comprehensive analysis of the French hospital infectious disease testing market, including: 

  • Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. 
  • Current scientific views on definition, epidemiology, and etiology of major infectious diseases and microorganisms. 
  • Volume and sales forecasts for 80 infectious disease tests performed in French hospital laboratories. 
  • Instrumentation technologies and feature comparison of leading analyzers. 
  • Sales and market shares of  leading suppliers by test.  
  • Emerging diagnostic technologies and their potential market applications. 
  • Product development opportunities.
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. 
  • Business opportunities and strategic recommendations for suppliers.
  • Business opportunities and strategic recommendations for suppliers.

    Contains 897 pages and 77 tables

    Table Of Contents

    2017-2021 France Hospital Infectious Disease Market: Emerging Opportunities and Growth Strategies for Suppliers
    Introduction
    Worldwide Market and Technology Overview
    A. Major Infectious Disease Tests
    1. AIDS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    2. Adenovirus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    d. Adeno-Associated Viruses(AAV)
    3. Aeromonas
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    4. Anthrax/Bacillus Anthracis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    5. Arboviruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    6. Babesiosis
    a. Background
    7. Bacillary Epithelioid Angiomatosis (BEA)
    And Other Bartonella (Rochalimaea)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    8. Blastocystis Hominis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs

    9. Brucella
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    10. Campylobacter
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    11. Candida
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    12. Chagas Disease
    a. Background
    13. Chancroid
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    14. Chlamydia
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    15. Clostridium Difficile
    a. Background
    b. Diagnostic Tests
    c. Drugs and Vaccines
    16. Coronaviruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    17. Coxsackieviruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    18. Creutzfeldt-Jakob's Disease
    a. Background
    b. Diagnostic Tests
    c. Vaccines

    19. Cryptosporidium Parvum
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    20. Cyclospora Cayetanensis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    21. Cytomegalovirus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    22. Ebola Virus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    23. E. Coli
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    24. EchoVirus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    25. Encephalitis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    26. Enteroviruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    27. Epstein-Barr Virus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    28. Giardia Lamblia
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs

    29. Gonorrhea
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    30. Granuloma Inguinale
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    31. Hantavirus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    32. Helicobacter Pylori
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    33. Hepatitis
    a. Background
    b. Hepatitis A
    c. Hepatitis B
    d. Hepatitis C
    e. Vaccines and Drugs
    34. Herpes Simplex Virus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    35. Human Herpes Virus-6 (HHV-6)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    36. Influenza Viruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    37. Legionella
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs

    38. Lyme Disease
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    39. Lymphogranuloma Venereum (LGV)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    40. Malaria
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    41. Measles (Rubeola)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    42. Meningitis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    43. Microsporidium
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    44. Mononucleosis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    45. Mumps
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    46. Mycoplasma
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    47. Papillomaviruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs

    48. Parvovirus B19
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    49. Pneumonia
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    50. Polyomaviruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    51. Pseudomonas Aeruginosa
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    52. Rabies
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    53. Respiratory Syncytial Virus (RSV)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    54. RhinoViruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    55. RotaVirus (REOVIRUS)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    56. Rubella(MEASLES)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    57. Salmonellosis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs

    58. Septicemia
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    59. Shigellosis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    60. Staphylococcus Aureus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    61. Streptococci
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    62. Syphilis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    63. Toxoplasmosis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    64. Trichomonas Vaginalis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    65. Tuberculosis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    66. Vibrio
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    67. West Nile Virus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs

    68. Yersina
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    B. Instrumentation Review of Leading Analyzers Marketed
    by Abbott, Beckman Coulter/Danaher, BioMerieux,
    Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
    Wallac and Other Suppliers
    C. Emerging Diagnostic Technologies
    1. Molecular Diagnostics
    2. Monoclonal Antibodies
    3. Immunoassays
    4. Differential Light Scattering
    5. Information Technology
    6. Artificial Intelligence
    7. Liposomes
    8. Flow Cytometry
    9. Chromatography
    10. Diagnostic Imaging
    11. Gel Microdroplets
    12. Other
    France
    A. Executive Summary
    B. Business Environment
    C. Market Structure
    D. Market Size, Growth and Major Suppliers
    Major Product Development Opportunities
    A. Instrumentation
    B. Reagent Kits and Test Systems/Panels
    C. Computers, Software and Automation
    D. Auxiliary Products
    Design Criteria for Decentralized Testing Products
    Alternative Market Penetration Strategies
    A. Internal Development
    B. Collaborative Arrangements

    C. University Contracts
    D. Distribution Strategies for Decentralized
    Testing Markets
    1. Marketing Approaches
    2. Product Complexity
    3. Customer Preference
    4. Established Suppliers
    5. Emerging Suppliers
    6. Major Types of Distributors
    7. Market Segmentation
    Potential Market Entry Barriers and Risks
    A. Market Maturity
    B. Cost Containment
    C. Competition
    D. Technological Edge and Limitations
    E. Patent Protection
    F. Regulatory Constraints
    G. Decentralized Testing Market Challenges
    Competitive Assessments
    - Abbott
    - Affymetrix
    - Beckman Coulter/Danaher
    - Becton Dickinson
    - bioMerieux
    - Bio-Rad
    - Cepheid
    - Diamedix/Erba
    - DiaSorin
    - Eiken Chemical
    - Elitech Group
    - Enzo Biochem
    - Fujirebio
    - Grifols
    - Hologic/Gen-Probe

    - ID Biomedical/GSK
    - Kreatech/Leica
    - Lonza
    - Ortho-Clinical Diagnostics
    - Qiagen
    - Roche
    - Scienion
    - Sequenom
    - SeraCare
    - Siemens
    - Takara Bio
    - Thermo Fisher
    - Wallac/PE
    - Wako


    List of Tables
    Major Companies Developing or Marketing AIDS Tests
    Major Companies Developing or Marketing Adenovirus
    Tests
    Major Companies Developing or Marketing Bartonella
    Tests
    Major Companies Developing or Marketing
    Campylobacter Tests
    Major Companies Developing or Marketing Candida
    Tests
    Major Companies Developing or Marketing Chlamydia
    Tests
    Major Companies Developing or Marketing Clostridium
    Tests
    Major Companies Developing or Marketing Coronavirus
    Tests
    Major Companies Developing or Marketing Cryptosporidium
    Tests
    Major Companies Developing or Marketing CMV Tests
    Major Companies Developing or Marketing Echovirus
    Tests
    Major Companies Developing or Marketing Enterovirus
    Tests
    Major Companies Developing or Marketing EBV Tests

    Major Companies Developing or Marketing Giardia
    Tests
    Major Companies Developing or Marketing Gonorrhea
    Tests
    Major Companies Developing or Marketing Hantavirus
    Tests
    Major Companies Developing or Marketing Helicobacter
    Pylori Tests
    Major Companies Developing or Marketing Hepatitis
    Tests
    Major Companies Developing or Marketing Herpes
    Tests
    Major Companies Developing or Marketing Influenza
    Tests
    Major Companies Developing or Marketing Legionella
    Tests
    Major Companies Developing or Marketing Lyme Disease
    Tests
    Major Companies Developing or Marketing Lymphogranuloma
    Tests
    Major Companies Developing or Marketing Malaria
    Tests
    Major Companies Developing or Marketing Measles
    Tests
    Major Companies Developing or Marketing Meningitis
    Tests

    Major Companies Developing or Marketing Microsporidium
    Tests
    Major Companies Developing or Marketing
    Mononucleosis Tests
    Major Companies Developing or Marketing Mumps Tests
    Major Companies Developing or Marketing Mycoplasma
    Tests
    Major Companies Developing or Marketing Papilloma
    Virus Tests
    Major Companies Developing or Marketing Parvovirus
    Tests
    Major Companies Developing or Marketing Pneumonia
    Tests
    Major Companies Developing or Marketing RSV Tests
    Major Companies Developing or Marketing Rotavirus
    Tests
    Major Companies Developing or Marketing Rubella
    Tests
    Major Companies Developing or Marketing Salmonella
    Tests
    Major Companies Developing or Marketing Septicemia
    Tests
    Major Companies Developing or Marketing Shigella
    Tests
    Major Companies Developing or Marketing Staphylococci
    Tests

    Major Companies Developing or Marketing
    Streptococci Tests
    Major Companies Developing or Marketing Syphilis
    Tests
    Major Companies Developing or Marketing Toxoplasmosis
    Tests
    Major Companies Developing or Marketing Trichomonas
    Tests
    Major Companies Developing or Marketing Tuberculosis
    Tests
    Major Companies Developing or Marketing West Nile
    Tests
    Major Companies Developing or Marketing Yersinia Tests

    View This Report »

    Get Industry Insights. Simply.

    • Latest reports & slideshows with insights from top research analysts
    • 24 Million searchable statistics with tables, figures & datasets
    • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

  • $ 59500
  • Industry report
  • January 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...


Download Unlimited Documents from Trusted Public Sources

Psychotic Disorder Statistics in the UK

  • February 2017
    5 pages
  • Psychotic Disor...  

  • United Kingdom  

View report >

Blood Disease Statistics in the US

  • February 2017
    24 pages
  • Blood Disease  

    Hospital  

    Intensive Care  

  • United States  

View report >

Cancer Statistics in Australia - Forecast

  • February 2017
    4 pages
  • Cancer  

    Ovarian Cancer  

  • Australia  

    Oceania  

View report >

ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.